Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

February 9, 2011

James Grossman Elected as Managing Director at Hiscock & Barclay, LLP

James S. Grossman has been elected to serve as Managing Director of the Rochester office of Hiscock & Barclay, LLP. Grossman, a resident of Penfield, NY, will serve a three year term. Grossman's practice focuses in the areas of Real Property Tax and Condemnation, Corporate, Real Estate and Health Care and Human Services.

Grossman is a graduate of Brooklyn Law School and Hobart College and has been working in Real Estate Practice and Litigation since 1975. His clients include municipalities, school districts, developers, major industrial and commercial property owners, large regional not-for-profit corporations and small technology corporations. Grossman is the former President of the Monroe County Bar Association and is currently a member of several civic organizations and has received several awards including the Nathaniel Award for professional accomplishments and community service in furtherance of justice.

Hiscock & Barclay, LLP, listed as a "Top 250 Firm" by The National Law Journal, is a full-service, 200-attorney law firm, with offices throughout the major cities of New York State, as well as in Boston, Washington, D.C. and Toronto, providing comprehensive legal and business counsel to a diverse client base in 30 practice areas.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Massachusetts Federal Court Permits Sharing Clause in Protective Order in Products Liability Case

Alerts

NYS Court of Appeals Holds That Parent May Not Recover for Emotional Injuries in Prenatal-Injury Case

Alerts

Smarter Inventory Management for Pharmacies: Navigating Online Marketplace Compliance

Alerts

Emergency Wine Run, Now Legal: New York State Opens Retail-to-Retail Sales

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks